Single Use Ophthalmic Surgical Devices Market

By Product;

Forceps, Speculum, Nucleus Rotators & Choppers, Curettes, Cannulas, Knives, OVD and Others

By Application;

Diabetic Retinopathy, Cataract Surgery, Glaucoma Surgery, Refractive Surgery, Corneal Surgery, Vitreo-Retinal Surgery and Others

By End Use;

Hospitals, Ophthalmic Clinics, ASCs and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn159945577 Published Date: October, 2025 Updated Date: November, 2025

Single Use Ophthalmic Surgical Devices Market Overview

Single Use Ophthalmic Surgical Devices Market (USD Million)

Single Use Ophthalmic Surgical Devices Market was valued at USD 21,662.71 million in the year 2024. The size of this market is expected to increase to USD 31,512.29 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.5%.


Single Use Ophthalmic Surgical Devices Market

*Market size in USD million

CAGR 5.5 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.5 %
Market Size (2024)USD 21,662.71 Million
Market Size (2031)USD 31,512.29 Million
Market ConcentrationMedium
Report Pages349
21,662.71
2024
31,512.29
2031

Major Players

  • Alcon (Part of Novartis AG)
  • Johnson and Johnson Services, Inc.
  • ZEISS International
  • Bausch & Lomb Incorporated
  • STAAR SURGICAL
  • Hoya Corporation
  • Glaukos
  • Allergan
  • New World Medical, Inc
  • Oertli Instrumente AG

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Single Use Ophthalmic Surgical Devices Market

Fragmented - Highly competitive market without dominant players


The Single‑Use Ophthalmic Surgical Devices Market is rapidly expanding as eye surgery centers prefer disposables—including single‑use blades, cannulas, and viscoelastic applicators—to improve safety and eliminate sterilization needs. Roughly 65% of cataract and glaucoma procedures now use disposable kits for sterile, consistent workflows. These solutions offer improved infection prevention, standardized device performance, and simplified workflow execution.

Co‑Developed Enhancements Supporting Safety and Ergonomics
Close to 62% of product innovation results from collaborations among ophthalmologist-endorsed designers, device engineers, and clinical sterilization teams. These strategies involve designing ergonomic single‑use instruments, optimizing packaging protocols, and integrating safety‑adapted materials. The result is enhanced surgical control, reduced handling errors, and greater procedural uniformity across surgical environments.

Innovative Features Enhancing Sterility and Operative Efficiency
Recent technological advancements such as sterilized single‑use introducer systems, integrated injector platforms, and pre‑assembled surgical kits have improved operational efficiency and safety by over 64%. These innovations enable consistent device performance, minimized downtime, and simplified inventory management—enhancing overall surgical throughput.

Favorable Growth Outlook Backed by Safety Guidelines and Clinical Preference
With nearly 68% of ophthalmic surgeons preferring disposable devices to reduce sterilization errors and infection risk, the market’s future outlook remains strong. New developments in recyclable materials, hybrid disposable trays, and smart instrument tracking are driving a clear growth trajectory. Continued innovation and strategic collaboration efforts will solidify single‑use technology as standard in ophthalmic surgical practice.

Key Takeaways

  • Enhanced procedural-safety & infection-control — the shift toward single-use ophthalmic surgical devices is driven by growing emphasis on sterility, reducing cross-contamination risk and improving surgical outcomes.

  • Surging ophthalmic surgery volumes worldwide — rising prevalence of age-related eye disorders (cataract, glaucoma, diabetic retinopathy) and expanded access in ambulatory surgery centres fuel demand for disposable instruments.

  • Workflow-efficiency & kit-based innovation — availability of pre-sterilised, procedure-specific kits and ergonomic single-use tools streamline ophthalmic workflows, especially in high-throughput settings such as specialty eye clinics and ASCs.

  • Cost-, environmental & supply-chain constraints persist — despite benefits, higher recurring cost of disposables versus re-usables, medical-waste concerns and supply-chain dependencies remain major adoption barriers.

  • Strong growth opportunities in emerging markets — with improving healthcare infrastructure and rising surgical capacity in Asia-Pacific, Latin America and Middle East regions, the single-use ophthalmic device market presents significant upside.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Application
    3. Market Snapshot, By End Use
    4. Market Snapshot, By Region
  4. Single Use Ophthalmic Surgical Devices Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Prevalence of Eye Disorders
        2. Minimally Invasive Surgeries
        3. Enhanced Patient Safety and Infection Control
      2. Restraints
        1. High Cost of Single-Use Devices
        2. Environmental Concerns
        3. Lack of Reimbursement in Some Regions
      3. Opportunities
        1. Expanding Healthcare Access in Emerging Markets
        2. Growing Aging Population
        3. Technological Innovation and Customization
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Single Use Ophthalmic Surgical Devices Market, By Product, 2021 - 2031 (USD Million)
      1. Forceps
      2. Speculum
      3. Nucleus Rotators & Choppers
      4. Curettes
      5. Cannulas
      6. Knives
      7. OVD
      8. Others
    2. Single Use Ophthalmic Surgical Devices Market, By Application, 2021 - 2031 (USD Million)
      1. Diabetic Retinopathy
      2. Cataract Surgery
      3. Glaucoma Surgery
      4. Refractive Surgery
      5. Corneal Surgery
      6. Vitreo-Retinal Surgery
      7. Others
    3. Single Use Ophthalmic Surgical Devices Market, By End Use, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ophthalmic Clinics
      3. ASCs
      4. Others
    4. Single Use Ophthalmic Surgical Devices Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Alcon Inc.
      2. Johnson & Johnson Vision / J&J Vision Care
      3. Carl Zeiss Meditec AG
      4. Bausch + Lomb Corporation
      5. BVI (BVI Medical / BVI ophthalmic)
      6. Stephen Instruments
      7. Surgitrac Instruments
      8. Sterimedix Limited
      9. Corza Medical
      10. Accutome Inc.
      11. Rumex International
      12. Appasamy Associates
      13. MANI, Inc.
      14. Glaukos Corporation
      15. STAAR Surgical
  7. Analyst Views
  8. Future Outlook of the Market